features: Gynecological Cancer

SIENDO: long-term PFS findings of maintenance selinexor in TP53wt endometrial cancer

Endometrial cancer is the most common gynecological cancer, where approximately 417,000 cases and 100,000 deaths were reported worldwide in 2020.1…

First-line maintenance with olaparib monotherapy and in combination bevacizumab increases survival in advanced ovarian cancer

Over 75% of patients with ovarian cancer are diagnosed at an advanced stage, as early-stage disease is usually asymptomatic.1,2 The…

Multi-cancer detection and localization for more than 50 cancer types

The early detection of cancer improves outcomes for patients – in terms of both reducing treatment burden and improving the…